Zacks Investment Research on MSN
Neuronetics (STIM) reports Q1 loss, tops revenue estimates
Neuronetics (STIM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.21 per share a year ago. These figures are ...
ROCKAWAY, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...
E-stim may not be appropriate for everyone, but for many people this painless procedure is accelerating recovery and providing relief from painful or uncomfortable symptoms. Whether you’re recovering ...
If you're an athlete who regularly pushes your limits and could benefit from faster recovery between workouts, neuromuscular electrical stimulation, also known as e-stim might be for you, says Cedric ...
We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. Neuronetics, Inc. is placed sixth among them. Neuronetics, Inc. (NASDAQ:STIM) is a commercial-stage medical technology ...
Garland, April 19, 2025 (GLOBE NEWSWIRE) -- When it comes to maximizing your training without the use of stimulants like caffeine, non-stim pre-workouts are the go-to solution. Whether you're training ...
The Swedish rights organization unveils a new model for AI music training, backed by attribution tech from Sureel. By Robert Levine STIM, the Swedish collective management organization, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results